Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Case 35% Improvement Relative Risk Vitamin D for COVID-19  Meltzer et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 2,348 patients in the USA Fewer cases with higher vitamin D levels (not stat. sig., p=0.11) c19early.org Meltzer et al., JAMA Netw Open., March 2021 Favors vitamin D Favors control

Association of Vitamin D Levels, Race/Ethnicity, and Clinical Characteristics With COVID-19 Test Results

Meltzer et al., JAMA Netw Open., doi:10.1001/jamanetworkopen.2021.4117
Mar 2021  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 120 studies, recognized in 7 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
3,900+ studies for 60+ treatments. c19early.org
Retrospective 4,638 individuals with vitamin D levels within 1 year before COVID-19 testing, showing higher risk of COVID-19 PCR+ for vitamin D deficient individuals, and lower (but not statistically significant) cases for individuals using vitamin D supplementation.
This is the 56th of 195 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 5061 vigintillion).
risk of case, 34.6% lower, RR 0.65, p = 0.11, high D levels 61 of 1,097 (5.6%), low D levels 118 of 1,251 (9.4%), NNT 26, adjusted per study, inverted to make RR<1 favor high D levels, >40ng/mL vs. <20ng/mL, Table 2, Model 2.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Meltzer et al., 19 Mar 2021, retrospective, database analysis, USA, peer-reviewed, 6 authors.
This PaperVitamin DAll
Association of Vitamin D Levels, Race/Ethnicity, and Clinical Characteristics With COVID-19 Test Results
MD David O Meltzer, PhD Thomas J Best, PhD Hui Zhang, PhD Tamara Vokes, MD Vineet M Arora, MD, MPP Julian Solway
JAMA Network Open, doi:10.1001/jamanetworkopen.2021.4117
IMPORTANCE Deficient (ie, <20 ng/mL) or insufficient (ie, 20 to <30 ng/mL) 25-hydroxyvitamin D (also known as calcifediol) levels are more common in Black individuals than White individuals and are associated with increased coronavirus disease 2019 (COVID-19) risk. Whether COVID-19 risk is associated with differences in vitamin D levels of 30 ng/mL or greater is not known. OBJECTIVE To examine whether COVID-19 test results are associated with differences in vitamin D levels of 30 ng/mL or greater, including for White individuals and for Black individuals. DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study was conducted at an academic medical center in Chicago, Illinois. Participants included individuals with data on vitamin D
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Additional Contributions: Data from this study were provided by the Clinical Research Data Warehouse (CRDW) maintained by the Center for Research Informatics (CRI) at University of Chicago. The CRI is funded by Clinical and Translational Sciences Award from the Biological Sciences Division of the Institute for Translational Medicine. Thomas Sutton, MS, and Julie Johnson, PhD, MPH, RN (UChicago CRI), appended additional data to the CRDW for this analysis; they were not compensated for this contribution.
References
Baktash, Hosack, Patel, Vitamin D status and outcomes for hospitalised older patients with COVID-19, Postgrad Med J. Published online, doi:10.1136/postgradmedj-2020-138712
Benskin, A basic review of the preliminary evidence that COVID-19 risk and severity is increased in vitamin D deficiency, Front Public Health, doi:10.3389/fpubh.2020.00513
Bergman, Lindh, Björkhem-Bergman, Lindh, Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials, PLoS One, doi:10.1371/journal.pone.0065835
Bikle, Schwartz, Vitamin D Binding protein, total and free vitamin D levels in different physiological and pathophysiological conditions front, Endocrinol, doi:10.3389/fendo.2019.00317
Billington, Burt, Rose, Safety of high-dose vitamin D supplementation: secondary analysis of a randomized controlled trial, J Clin Endocrinol Metab, doi:10.1210/clinem/dgz212
Blizzard, Hosmer, Parameter estimation and goodness-of-fit in log binomial regression, Biom J, doi:10.1002/bimj.200410165
Boucher, Vitamin D status as a predictor of COVID-19 risk in Black, Asian and other ethnic minority groups in the UK, Diabetes Metab Res Rev, doi:10.1002/dmrr.3375
Bouillon, Schuit, Antonio, Rastinejad, Vitamin D binding protein: a historic overview, Front Endocrinol, doi:10.3389/fendo.2019.00910
Brown, Cohen, Tabor, Zappalà, Maruvada et al., The vitamin D paradox in Black Americans: a systems-based approach to investigating clinical practice, research, and public health-expert panel meeting report, BMC Proc, doi:10.1186/s12919-018-0102-4
Charoenngam, Holick, Immunologic effects of vitamin D on human health and disease, Nutrients, doi:10.3390/nu12072097
Dhaliwal, Mikhail, Feuerman, Aloia, The vitamin d dose response in obesity, Endocr Pract, doi:10.4158/EP13518.OR
Diagnostics, Zhang, Jx, Iwashyna, Christakis, The performance of different lookback periods and sources of information for Charlson comorbidity adjustment in Medicare claims, doi:10.1097/00005650-199911000-00005
Elliott, Binkley, Carnes, Fracture risks for women in long-term care: high prevalence of calcaneal osteoporosis and hypovitaminosis D, Pharmacotherapy, doi:10.1592/phco.23.6.702.32182
Forrest, Stuhldreher, Prevalence and correlates of vitamin D deficiency in US adults, Nutr Res, doi:10.1016/j.nutres.2010.12.001
Freedman, Register, Effect of race and genetics on vitamin D metabolism, bone and vascular health, Nat Rev Nephrol, doi:10.1038/nrneph.2012.112
Frieden, Former, Chief Dr, Tom Frieden, coronavirus infection risk may be reduced by vitamin D. Fox News
Garg, Kim, Whitaker, Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019-COVID-NET, 14 states, MMWR Morb Mortal Wkly Rep, doi:10.15585/mmwr.mm6915e3
Grant, Lahore, Mcdonnell, Infectious Diseases Association of Vitamin D Levels and Clinical Characteristics With COVID-19 Test Results, Nutrients, doi:10.3390/nu12040988
Hastie, Mackay, Ho, Vitamin D concentrations and COVID-19 infection in UK Biobank, Diabetes Metab Syndr, doi:10.1016/j.dsx.2020.04.050
Holick, Binkley, Bischoff-Ferrari, Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, doi:10.1210/jc.2011-0385
Huotari, Herzig, Vitamin D and living in northern latitudes-an endemic risk area for vitamin D deficiency, Int J Circumpolar Health, doi:10.3402/ijch.v67i2-3.18258
Israel, Cicurel, Feldhamer, Dror, Giveon et al., The link between vitamin D deficiency and COVID-19 in a large population medRxiv, doi:10.1101/2020.09.04.20188268
Kaufman, Niles, Kroll, Bi, Holick, SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels, PLoS One, doi:10.1371/journal.pone.0239252
Libon, Cavalier, Nikkels, Skin color is relevant to vitamin D synthesis, Dermatology, doi:10.1159/000354750
Looker, Johnson, Lacher, Vitamin D Status: United States 2001-2006
Maghbooli, Sahraian, Ebrahimi, Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection, PLoS One, doi:10.1371/journal.pone.0239799
Mardani, Alamdary, Nasab, Gholami, Ahmadi et al., Association of vitamin D with the modulation of the disease severity in COVID-19, Virus Res, doi:10.1016/j.virusres.2020.198148
Martineau, Jolliffe, Hooper, Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, BMJ, doi:10.1136/bmj.i6583
Mccall, Medical societies advise on vitamin D in midst of COVID-19, Medscape Medical News
Mccullagh, Nelder, Generalized Linear Models, doi:10.1007/978-1-4899-3242-6
Mccullough, Lehrer, Amend, Daily oral dosing of vitamin D 3 using 5000 to 50,000 international units a day in long-term hospitalized patients: insights from a seven year experience, J Steroid Biochem Mol Biol, doi:10.1016/j.jsbmb.2018.12.010
Mcnutt, Wu, Xue, Hafner, Estimating the relative risk in cohort studies and clinical trials of common outcomes, Am J Epidemiol, doi:10.1093/aje/kwg074
Meltzer, Best, Zhang, Vokes, Arora et al., Association of vitamin D status and other clinical characteristics with COVID-19 test results, JAMA Netw Open, doi:https://jama.jamanetwork.com/article.aspx?doi=10.1001/jamanetworkopen.2020.19722&utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamanetworkopen.2021.4117
Merzon, Tworowski, Gorohovski, Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study, FEBS J, doi:10.1111/febs.15495
Mohammad, Mishra, Ashraf, Emerging role of vitamin D and its associated molecules in pathways related to pathogenesis of thrombosis, Biomolecules, doi:10.3390/biom9110649
Oleröd, Hultén, Hammarsten, Klingberg, The variation in free 25-hydroxy vitamin D and vitamin D-binding protein with season and vitamin D status, Endocr Connect, doi:10.1530/EC-16-0078
Pregibon, Data Analytic Methods for Generalized Linear Models
Prietl, Treiber, Pieber, Amrein, Vitamin D and immune function, Nutrients, doi:10.3390/nu5072502
Ross, Dietary Reference Intakes for Calcium and Vitamin D
Sowah, Fan, Dennett, Hagtvedt, Straube, Vitamin D levels and deficiency with different occupations: a systematic review, BMC Public Health, doi:10.1186/s12889-017-4436-z
Supplement, Multivariable Association of Vitamin D Levels and Treatment with Test Results Positive for COVID-19 Among Individuals Reporting White Race eTable 2. COVID-19 Test Positivity Rate by Most Recent Vitamin D Level and by Time Since Most Recent Measurement eTable 3. Multivariable Association of Vitamin D Levels and Treatment with Test Results Positive for COVID-19 Among Individuals With No Active Vitamin D Treatment Before COVID-19 Test eTable 4. Multivariable Association of Vitamin D Levels and Treatment with Test Results Positive for COVID-19 Among Individuals With Active Vitamin D Treatment Before COVID-19 Test eFigure. COVID-19 Test Positivity Rate by Race and by Most Recent Vitamin D Levels Before COVID-19 Tests eAppendix, Supplemental Methods
Viracor, Coronavirus (COVID-19) SARS-CoV-2 RT-PCR
Xue, Moncla, Bedford, Bloom, Within-host evolution of human influenza virus, Trends Microbiol, doi:10.1016/j.tim.2018.02.007
Zhang, Fang, Tang, Association between vitamin D supplementation and mortality: systematic review and meta-analysis, BMJ, doi:10.1136/bmj.l4673
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit